Rap1b in Smooth Muscle and Endothelium Is Required for Maintenance of Vascular Tone and Normal Blood Pressure

Autor: Zhi-Dong Ge, David X. Zhang, Hayley Lund, Sribalaji Lakshmikanthan, Avril V. Somlyo, Bartosz J. Zieba, Xiaodong Zheng, David L. Mattson, Ko Momotani, John A. Auchampach, Mykhaylo V. Artamonov, Aniko Szabo, Jason E. Maas, Magdalena Chrzanowska-Wodnicka
Rok vydání: 2014
Předmět:
Male
Time Factors
Vasodilator Agents
Blood Pressure
Vasodilation
Plasma renin activity
Muscle
Smooth
Vascular

Mice
Vasoconstrictor Agents
Phosphorylation
vasodilation
Cells
Cultured

Mice
Knockout

Losartan
medicine.anatomical_structure
Hypertension
Female
RNA Interference
medicine.symptom
Cardiology and Cardiovascular Medicine
signal transduction
Signal Transduction
medicine.drug
medicine.medical_specialty
Nitric Oxide Synthase Type III
Endothelium
Myocytes
Smooth Muscle

Cardiomegaly
Biology
Nitric Oxide
Transfection
Article
relaxation
Internal medicine
medicine
Animals
Humans
Antihypertensive Agents
Dose-Response Relationship
Drug

Endothelial Cells
medicine.disease
Angiotensin II
rap GTP-Binding Proteins
Blood pressure
Endocrinology
Vasoconstriction
Pathophysiology of hypertension
Angiotensin II Type 1 Receptor Blockers
Zdroj: Arteriosclerosis, Thrombosis, and Vascular Biology. 34:1486-1494
ISSN: 1524-4636
1079-5642
DOI: 10.1161/atvbaha.114.303678
Popis: Objective— Small GTPase Ras-related protein 1 (Rap1b) controls several basic cellular phenomena, and its deletion in mice leads to several cardiovascular defects, including impaired adhesion of blood cells and defective angiogenesis. We found that Rap1b −/− mice develop cardiac hypertrophy and hypertension. Therefore, we examined the function of Rap1b in regulation of blood pressure. Approach and Results— Rap1b −/− mice developed cardiac hypertrophy and elevated blood pressure, but maintained a normal heart rate. Correcting elevated blood pressure with losartan, an angiotensin II type 1 receptor antagonist, alleviated cardiac hypertrophy in Rap1b −/− mice, suggesting a possibility that cardiac hypertrophy develops secondary to hypertension. The indices of renal function and plasma renin activity were normal in Rap1b −/− mice. Ex vivo, we examined whether the effect of Rap1b deletion on smooth muscle–mediated vessel contraction and endothelium-dependent vessel dilation, 2 major mechanisms controlling basal vascular tone, was the basis for the hypertension. We found increased contractility on stimulation with a thromboxane analog or angiotensin II or phenylephrine along with increased inhibitory phosphorylation of myosin phosphatase under basal conditions consistent with elevated basal tone and the observed hypertension. Cyclic adenosine monophosphate–dependent relaxation in response to Rap1 activator, Epac, was decreased in vessels from Rap1b −/− mice. Defective endothelial release of dilatory nitric oxide in response to elevated blood flow leads to hypertension. We found that nitric oxide–dependent vasodilation was significantly inhibited in Rap1b-deficient vessels. Conclusions— This is the first report to indicate that Rap1b in both smooth muscle and endothelium plays a key role in maintaining blood pressure by controlling normal vascular tone.
Databáze: OpenAIRE